Fig. 2

Outcomes after 6 months of therapy. a HbA1c, b Body weight. Both parameters showed significant reductions over the 6 months of the study. At baseline, the HbA1c levels were significantly higher and body weight did not differ in comparison to Visit −1. These changes were evaluated using Student’s t-test versus the beginning of administration. Values are mean ± SD. ** P < 0.01